(R)-Ketorolac ((+)-Ketorolac) is the R-enantiomer of ketorolac that functions as a selective allosteric inhibitor of the small GTPases Cdc42 and Rac1, blocking GTP binding and downstream signaling pathways like PAK activation. It exhibits the potential for repurposing as an anti-metastatic agent in ovarian cancer.